Experience in managing patients of reproductive age with dyshormonal diseases of the mammary glands
This article presents the results of own research of the Indol-F® efficacy and safety in the treatment of 86 patients of reproductive age with a dysplasia of mammary glands for 3 months. Comparison was carried out with 50 women who were under dynamic observation. Improvement of mammary glands status...
Main Authors: | S. A. Lasachko, I. M. Shakalo |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House TRILIST
2020-11-01
|
Series: | Репродуктивная эндокринология |
Subjects: | |
Online Access: | http://reproduct-endo.com/article/view/218468 |
Similar Items
-
Comparative evaluation of the efficiency of complex bioactive indol and vitex-containing medicines in treatment of dishormonal dysplasia of the mammary glands
by: В. І. Пирогова, et al.
Published: (2019-12-01) -
Mammary gland condition in premenopausal women with endometrial hyperplasia
by: Y. E. Dobrokhotova, et al.
Published: (2021-04-01) -
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24- Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet)
by: Simone Lucarini, et al.
Published: (2010-06-01) -
The Effect of Indole-3-Carbinol and 3,3'-Diindolylmethane on Fatty Acid Synthase and Sp1 in Breast Cancer Cells
by: Saati, George
Published: (2009) -
The Effect of Indole-3-Carbinol and 3,3'-Diindolylmethane on Fatty Acid Synthase and Sp1 in Breast Cancer Cells
by: Saati, George
Published: (2009)